AstraZeneca's Tagrisso gets CHMP nod for EU approval

Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca, said: “Today's news reinforces Tagrisso as the backbone therapy in EGFR- ...

AstraZeneca's Tagrisso Gets Nod From EMA's CHMP in ...

If approved by the EC, Tagrisso will be the first targeted therapy for European patients with unresectable EGFR-mutated cancer.

CHMP recommends AstraZeneca's Tagrisso for EU approval for ...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's Tagrisso (osimertinib) ...

AstraZeneca's Tagrisso gets CHMP nod for EU approval

AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) has received a recommendation for approval from the Committee for Medicinal Products for Human Use ...

AstraZeneca's Tagrisso recommended for approval in EU by CHMP ...

AstraZeneca's (AZN) Tagrisso has been recommended for approval in the European Union for the treatment of adult patients with locally ...

AstraZeneca's Tagrisso Gains EU Approval Nod - TipRanks.com

AstraZeneca (GB:AZN) has released an update. AstraZeneca's Tagrisso has been recommended for approval in the EU for treating advanced, ...

AstraZeneca Tagrisso recommended for approval in EU by CHMP ...

Cambridge: AstraZeneca's Tagrisso (osimertinib) has been recommended for approval in the European Union (EU) for the treatment of adult ...

TOP NEWS: AstraZeneca hails recommended EU approval of Tagrisso

(Alliance News) - AstraZeneca PLC on Monday said that the EU's Committee for Medicinal Products for Human Use, or CHMP, recommended its ...

Hutchmed, AstraZeneca to Discuss Orpathys, Tagrisso Trial Results ...

AstraZeneca's Tagrisso Gets Nod From EMA's CHMP in Unresectable EGFR-Mutated NSCLC · AbbVie's Elahere Approved in Europe for FRα-Positive ...

Tagrisso moves closer towards EU approval for early-stage lung ...

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca's (AZ) Tagrisso for ...

AstraZeneca drug Tagrisso gets EU nod for early lung cancer ...

AstraZeneca's (AZN.L) top-selling Tagrisso drug has been approved for use in the European Union to treat patients with a type of early-stage ...

EU gives conditional approval to novel drug for NSCLC

Leading drug manufacturer AstraZeneca on Friday announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

J&J gets CHMP nod for Rybrevant in first-line lung cancer

CHMP backs EU approval of J&J's Rybrevant as a first-line therapy ... AstraZeneca's market-leading EGFR inhibitor Tagrisso (osimertinib).

Regulatory tracker: Merck's Keytruda picks up 2 new approvals in ...

The number of approved indications for Merck's star cancer medicine Keytruda has grown to 26 in Europe. Most recently, the European Commission approved the drug ...

Regulatory tracker: FDA turns away Astellas' label update bid for GA ...

AstraZeneca and Daiichi Sankyo's Enhertu picked up a new conditional approval from China's National Medical Products Administration. With the nod, the drug can ...

Mixed bag of recommendations in latest CHMP update

The duo was approved by the FDA in August for frontline NSCLC, where it is seeking to displace AstraZeneca's Tagrisso (osimertinib) as the ...

Pfizer closes on EU approval of lung cancer drug Vizimpro - PMLiVE

Among the clutch of decisions at the last CHMP meeting was a recommendation for approval of Pfizer's Vizimpro, an EGFR-targeting drug that ...

AstraZeneca Enhertu recommended for nod in EU by CHMP for ...

Cambridge: AstraZeneca and Daiichi Sankyo's (trastuzumab deruxtecan) has been recommended for approval ... approved therapies. ... Tagrisso plus chemotherapy to ...